These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32387489)

  • 21. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag reflex, or discomfort during intensity-modulated radiation therapy.
    Kil WJ; Kulasekere C; Derrwaldt R; Bugno J; Hatch C
    Oncotarget; 2016 Aug; 7(33):53029-53036. PubMed ID: 27447973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation-induced trismus in head and neck cancer patients.
    Louise Kent M; Brennan MT; Noll JL; Fox PC; Burri SH; Hunter JC; Lockhart PB
    Support Care Cancer; 2008 Mar; 16(3):305-9. PubMed ID: 17965892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
    Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus.
    Hsiung CY; Huang EY; Ting HM; Huang HY
    Br J Radiol; 2008 Oct; 81(970):809-14. PubMed ID: 18591201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging.
    Hsieh LC; Chen JW; Wang LY; Tsang YM; Shueng PW; Liao LJ; Lo WC; Lin YC; Tseng CF; Kuo YS; Jhuang JY; Tien HJ; Juan HF; Hsieh CH
    PLoS One; 2014; 9(3):e92561. PubMed ID: 24658376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
    Karpf D; Sakka M; Metzger M; Grabenbauer GG
    Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
    Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Lu C; Goepfert RP; Fuller CD; Lai SY; Gunn GB; Chambers MS; Sturgis EM; Hanna EY; Shete S
    Cancer; 2021 Dec; 127(23):4470-4480. PubMed ID: 34358341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation-induced trismus in the ARTSCAN head and neck trial.
    Lindblom U; Gärskog O; Kjellén E; Laurell G; Levring Jäghagen E; Wahlberg P; Zackrisson B; Nilsson P
    Acta Oncol; 2014 May; 53(5):620-7. PubMed ID: 24669774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
    Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
    Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
    Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
    Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
    Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Goepfert RP; Duvall A; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Shete S
    JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):615-623. PubMed ID: 33956062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitive radiotherapy and trismus in HNC patients: A critical review.
    Spahiu O; Grossi C; Cavallin C; Chiofalo V; Cuffini EM; Lo Zito B; Catena F; Tortarolo A; Levis M; Piancino MG; Ricardi U; Iorio GC
    Crit Rev Oncol Hematol; 2024 Nov; 203():104486. PubMed ID: 39197668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal patterns of patient-reported trismus and associated mouth-opening distances in radiotherapy for head and neck cancer: A prospective cohort study.
    Thor M; Olsson CE; Oh JH; Hedström J; Pauli N; Johansson M; Deasy JO; Finizia C
    Clin Otolaryngol; 2018 Feb; 43(1):22-30. PubMed ID: 28463432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation.
    Karsten RT; Chargi N; van der Molen L; van Son RJJH; de Bree R; Al-Mamgani A; de Boer JP; Hilgers FJM; van den Brekel MWM; Smeele LE; Stuiver MM
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):1003-1027. PubMed ID: 34043065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
    Mohindra P; Urban E; Pagan JD; Geye HM; Patel VB; Bayliss RA; Bender ET; Harari PM
    Head Neck; 2016 Apr; 38(4):499-505. PubMed ID: 25445257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
    Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.